by Kiran Musunuru, and Sekar Kathiresan

Slides:

Advertisements

Similar presentations

YOUR CHOLESTEROL WHY DO YOU CARE? WHAT YOU CAN DO !

Advertisements

Lipoprotein Structure, Function, and Metabolism

Cholesterol Lipid Component of cell membrane Found in the diet – Eggs, dairy, liver High levels lead to development of CHD 2 types of cholesterol -carrying.

Lipoproteins Clusters of lipids associated with proteins that serve as transport vehicles for lipids in the lymph and blood.

Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.

 The third major class of lipids  The three cyclohexane rings (A, B, C) are connected to a cyclopentane ring (D).  Significantly different structure.

Cholesterol is among the lipids (fats) in the bloodstream. Source: Supplied from diet or synthesized by liver. Importance: 1.Form cell membranes and.

By: David Tran, Mercer University, 2013 Pharm.D. Candidate Prececptor: Dr. Ali Rahimi Morbidity and Mortality Associated with Dyslipidemia.

Cholesterol Cholesterol is a soft, fat-like, waxy lipid attached to a protein (called a lipoprotein) found in the bloodstream and in all your body's cells.

© 2003, Wellsource Inc. Effect of Ketogenic Diet on Lipid Levels (shown is LDL-C) In this group of 141 children followed for 6 months, a ketogenic diet.

Low-density Lipoprotein Cholesterol, Familial Hypercholesterolemia Mutation Status, and Risk for Coronary Artery Disease Amit V. Khera, Hong-Hee Won, Gina.

Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid.

Parameters BD PP CP TC (mg. dl-l) ± * ± 5.8

Date of download: 11/12/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Apolipoprotein E Genotypes With Lipid.

Dyslipidemia and Diabetic Macular Edema

Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J

Interrupting bile-acid handling and lipid and glucose control: Effects of colesevelam on glucose levels Michael H. Davidson, MD Journal of Clinical.

Copyright © 2011 American Medical Association. All rights reserved.

A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality Rishi K. Wadhera,

by Hiroyuki Morita, and Issei Komuro

Copyright © 2001 American Medical Association. All rights reserved.

The effects of apo E alleles on various lipoprotein parameters

Copyright © 2012 American Medical Association. All rights reserved.

Arterioscler Thromb Vasc Biol

Nat. Rev. Cardiol. doi: /nrcardio

Arterioscler Thromb Vasc Biol

by Salim Yusuf, and Sonia Anand

Old Drug, New Tricks by Alan T. Remaley Circulation Research

Association of Lipids With Incident Heart Failure Among Adults With and Without Diabetes MellitusClinical Perspective by Imo A. Ebong, David C. Goff, Carlos.

Impact of Genetic Variants in Human Scavenger Receptor Class B Type I (SCARB1) on Plasma Lipid TraitsCLINICAL PERSPECTIVE by Vipavee Niemsiri, Xingbin.

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Plasma Vitamin C, but Not Vitamin E, Is Associated With Reduced Risk of Heart Failure in Older MenClinical Perspective by Sasiwarang Goya Wannamethee,

Association of Rare Loss-Of-Function Alleles in HAL, Serum HistidineCLINICAL PERSPECTIVE by Bing Yu, Alexander H. Li, Donna Muzny, Narayanan Veeraraghavan,

Integromic Analysis of Genetic Variation and Gene Expression Identifies Networks for Cardiovascular Disease PhenotypesCLINICAL PERSPECTIVE by Chen Yao,

ONLINE SUPPLEMENTAL MATERIAL

So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients

Effect of Low Cholesterol on Steroid Hormones and Vitamin E Levels

Behavior and Biology: The Basic Sciences for AHA Action

Apoprotein B, Small-Dense LDL and Impaired HDL Remodeling Is Associated With Larger Plaque Burden and More Noncalcified Plaque as Assessed by Coronary.

by John T. Wilkins, Hongyan Ning, Neil J. Stone, Michael H

Figure 7 Mendelian randomization of overlapping exposures

Volume 148, Issue 4, Pages (April 2015)

What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs? Raul D. Santos Atherosclerosis.

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality Rishi K. Wadhera,

Jonathan C. Cohen, PhD Journal of Clinical Lipidology

II. assessment of dyslipidemias

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.

APOC3, Coronary Disease, and Complexities of Mendelian Randomization

Description of studies for pooled analyses

Dual Role of Circulating Angiopoietin-Like 4 (ANGPTL4) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome Nosratola D.

Copyright © 2016 Elsevier Inc. All rights reserved.

To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B? Carl J. Lavie, MD, Richard V. Milani, MD, James.

Toward Individualized Cholesterol-Lowering Treatment in End-Stage Renal Disease Guenther Silbernagel, MD, Iris Baumgartner, MD, Christoph Wanner, MD,

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Baseline Characteristics of the Subjects*

(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.

Schematic representation of dyslipidaemia of metabolic syndrome.

Characteristics of included studies

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease Dean G. Karalis, MD Mayo Clinic Proceedings

Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm

Lipoproteins Macromolecular complexes in the blood that transport lipids Apolipoproteins Proteins on the surface of lipoproteins; they play critical.

III. Treating dyslipidemias

Genome-wide Characterization of Shared and Distinct Genetic Components that Influence Blood Lipid Levels in Ethnically Diverse Human Populations Marc A.

Plasma lipid exchange. Plasma lipid exchange. In the presence of increased concentrations of VLDL in the circulation, cholesteryl ester transfer protein.

Individual lipid measures for high-carbohydrate (n=10) and low-carbohydrate (n=10) ultra-endurance athletes. Individual lipid measures for high-carbohydrate.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Presentation transcript:

by Kiran Musunuru, and Sekar Kathiresan Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis by Kiran Musunuru, and Sekar Kathiresan Circulation Research Volume 118(4):579-585 February 19, 2016 Copyright © American Heart Association, Inc. All rights reserved.

The cumulative effects of genetic variants that raise plasma low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG) levels on the risk of myocardial infarction (MI). The cumulative effects of genetic variants that raise plasma low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG) levels on the risk of myocardial infarction (MI). SD indicates standard deviation. Kiran Musunuru, and Sekar Kathiresan Circ Res. 2016;118:579-585 Copyright © American Heart Association, Inc. All rights reserved.

Lipid-associated and nonlipid-associated genes identified in a genome-wide association study (GWAS) on coronary heart disease (CHD). Lipid-associated and nonlipid-associated genes identified in a genome-wide association study (GWAS) on coronary heart disease (CHD). ABCG5/G8 indicates ATP-binding cassette sub-family G member 5/8; ABO, ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase); LIPA, lipase A, lysosomal acid, cholesterol esterase; LPL, lipoprotein lipase; SH2B3, SH2B adaptor protein 3; SORT1, sortilin 1; and TCF21, transcription factor 21. Kiran Musunuru, and Sekar Kathiresan Circ Res. 2016;118:579-585 Copyright © American Heart Association, Inc. All rights reserved.